Moreover, SIRT1- and DBC1-related pathways may be involved in the progression of soft-tissue sarcomas and SIRT1- and DBC1-related pathways may provide targets for novel therapeutic approaches for soft-tissue sarcomas. Here, SIRT1 is linked to soft tissue sarcoma.